Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent granted for Lyme test technology:

This article was originally published in Clinica

Executive Summary

The Mayo Foundation has gained a US patent covering the technology used in Imugen's Lyme infection test, which the Norwood, Massachusetts-based company licenses from the Foundation. The test is able to identify Lyme infection even in people who have recently received the Lyme vaccine - this is important because people in endemic areas may be at risk of contracting Lyme disease while undergoing vaccine regimens (the vaccine is maximally effective after three doses).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076667

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel